Novartis Oncology Auditor Salaries in Baltimore, MD | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Auditor Salaries in Baltimore, MD

The average Novartis Oncology Auditor in Baltimore, MD earns an estimated $80,691 annually. Novartis Oncology's Auditor compensation is $3,705 less than the US average for a Auditor.

In Baltimore, MD, The Finance Department at Novartis Oncology earns $7,429 more on average than the Operations Department.

Last updated 3 years ago.

$27k
$41k
$57k
$73k
$282k
$340k
$450k
$80,691
Average Compensation
$80,691
avg. base

Auditor Salaries at Novartis Oncology

In Baltimore, MD, Auditors earn $2,852 more than Senior Accountants, and $8,325 less than Business Analysts.

Accounting Manager
$119k*
Financial Analyst
$89k*
Business Analyst
$89k*
Senior Accountant
$78k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Baltimore, MD, The Finance Department averages $7,429 more than the Operations Department, and $11,203 less than the Business Development Department

Business Development
$95,491 Avg. total comp.
+$11k
Finance
$84,288 Avg. total comp.
Operations
$76,859 Avg. total comp.
-$7k

Auditor Compensation by Gender (All Companies)

The average female Auditor at companies similar size to Novartis Oncology reported making $88,019, while the average male Auditor at similar sized companies reported making $86,640.

Auditor Compensation by Ethnicity (All Companies)

The average Hispanic or Latino Auditor at companies similar size to Novartis Oncology reported making $111,857, while the average African American/Black Auditor at similar sized companies reported making $67,169.

How Auditors at Novartis Oncology Rate Their Compensation

The majority of Auditors at Novartis Oncology believe they're not compensated fairly. 100% of Auditors at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company